New Insights Into the Role of Ca v 2 Protein Family in Calcium Flux Deregulation in Fmr1 -KO Neurons
Fragile X syndrome (FXS), the most common form of inherited intellectual disability (ID) and a leading cause of autism, results from the loss of expression of the gene which encodes the RNA-binding protein Fragile X Mental Retardation Protein (FMRP). Among the thousands mRNA targets of FMRP, numerou...
Gespeichert in:
Veröffentlicht in: | Frontiers in molecular neuroscience 2018, Vol.11, p.342 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Fragile X syndrome (FXS), the most common form of inherited intellectual disability (ID) and a leading cause of autism, results from the loss of expression of the
gene which encodes the RNA-binding protein Fragile X Mental Retardation Protein (FMRP). Among the thousands mRNA targets of FMRP, numerous encode regulators of ion homeostasis. It has also been described that FMRP directly interacts with Ca
channels modulating their activity. Collectively these findings suggest that FMRP plays critical roles in Ca
homeostasis during nervous system development. We carried out a functional analysis of Ca
regulation using a calcium imaging approach in
-KO cultured neurons and we show that these cells display impaired steady state Ca
concentration and an altered entry of Ca
after KCl-triggered depolarization. Consistent with these data, we show that the protein product of the
gene, the pore-forming subunit of the Ca
2.1 channel, is less expressed at the plasma membrane of
-KO neurons compared to wild-type (WT). Thus, our findings point out the critical role that Ca
2.1 plays in the altered Ca
flux in
-KO neurons, impacting Ca
homeostasis of these cells. Remarkably, we highlight a new phenotype of cultured
-KO neurons that can be considered a novel cellular biomarker and is amenable to small molecule screening and identification of new drugs to treat FXS. |
---|---|
ISSN: | 1662-5099 1662-5099 |